Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Lang

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
QJM : Monthly Journal of the Association of Physicians|February 26, 2010
Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?D H J Elder, M Pauriah, C C Lang, et al.
BMJ Open|November 1, 2016
Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trialV Eyre, C C Lang, K Smith, et al.
Trials|August 15, 2022
Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21A Morrow, Stuart R Gray, H K Bayes, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Journal of Internal Medicine|May 7, 2020
Tumour biomarkers: association with heart failure outcomesC Shi, H H van der Wal, H H W Silljé, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
QJM : Monthly Journal of the Association of Physicians|February 26, 2010
Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?D H J Elder, M Pauriah, C C Lang, et al.
BMJ Open|November 1, 2016
Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trialV Eyre, C C Lang, K Smith, et al.
Trials|August 15, 2022
Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21A Morrow, Stuart R Gray, H K Bayes, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Journal of Internal Medicine|May 7, 2020
Tumour biomarkers: association with heart failure outcomesC Shi, H H van der Wal, H H W Silljé, et al.
Pageof 11